Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1
This study showed that rechallenge trastuzumab-based therapy was effective and good-tolerated in heavily pretreated patients who had progressed under TDM-1.
Source: Indian Journal of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Anemia | Breast Cancer | Breast Lumpectomy | Breast Surgery | Cancer | Cancer & Oncology | Chemotherapy | Endocrine Therapy | HER2 | Herceptin | India Health | Lumpectomy | Mastectomy | Palliative | Study | Toxicology